Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Import Program Would Need Funds To Inspect All U.S. Pharmacies, Agency Maintains

This article was originally published in The Pink Sheet Daily

Executive Summary

The pharmacy industry has told FDA all U.S. pharmacies will need to participate in a drug importation program to stay in business, so up to 55,000 pharmacies would have to be inspected, FDA's McGinnis says. "Draconian" penalties for non-complying drug manufacturers would ensure ample flow of drugs from Canada, he says.
Advertisement

Related Content

AARP Will Continue To Support Dorgan/Snowe Drug Import Bill In 2005
AARP Will Continue To Support Dorgan/Snowe Drug Import Bill In 2005
Rx Import Bills Do Not Have Adequate Funding For FDA, Agency Says
Rx Import Bills Do Not Have Adequate Funding For FDA, Agency Says
FDA Working To Put A Price Tag On Ensuring Safety Of Personal Drug Imports
FDA Working To Put A Price Tag On Ensuring Safety Of Personal Drug Imports
AARP Endorses Dorgan Import Bill; Sponsors Will Push For Floor Vote In Senate
Gregg Reimportation Plan Is FDA-Approved, Sponsors Say
Gregg Reimportation Plan Is FDA-Approved, Sponsors Say
Drug Importation Could Cause Increase In Illegal Internet Rx Sales, FDA Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS059679

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel